Hidradenitis suppurativa is a debilitating disorder that can be difficult to manage with current conventional treatment strategies. Given its association with proinflammatory cytokines there has been interest in the use of novel biological monoclonal antibodies. We describe our experience with the use of these agents in six patients in whom conventional treatment had failed, with promising response noted in some patients. A growing number of studies now highlight the efficacy of these agents.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajd.12136 | DOI Listing |
Publication Analysis
Top Keywords
hidradenitis suppurativa
8
conventional treatment
8
moderate severe
4
severe hidradenitis
4
suppurativa treated
4
treated biological
4
biological therapies
4
therapies hidradenitis
4
suppurativa debilitating
4
debilitating disorder
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!